Table 2

Most significantly associated rare variants in the family-based association test and their predicted pathogenicity*

Chr:BP (hg19)dbSNP identifierGeneReference allele/ alternative alleleVariant typePolyPhenCADD Phred scoreDANN scoreAlternative allele countPedigree (per-family LOD)
10:52005095rs116049719ASAH2G/ANonsense350.99749131 (0.31)
18 (0.42)§
1 (0.68)
74 (−0.03)
10:55566719rs570828018PCDH15G/AMissenseDamaging19.180.99845138 (0.43)
10:55581787NovelPCDH15T/AMissenseBenign230.9664518 (0.42)§
10:64967951rs139722368JMJD1CCTAAAC/−Indel19.0515129 (0.24)
138 (0.43)
19 (−0.124)
10:64974380rs41274074JMJD1CG/CMissenseBenign15.640.888015129 (0.24)
138 (0.43)
19 (−0.124)
10:61815652rs780899852ANK3G/CMissenseDamaging24.30.9927518 (0.42)§
10:64913602rs62623680NRBF2A/GMissenseDamaging28.30.9980617 (0.57)
  • CADD = Combined Annotation Dependent Depletion; Chr:BP (hg19) = the chromosome (chr) and base pair (BP) position of each variant, based on Genome Reference Consortium Human Build 37 (GRCh37/hg19); DANN = Deleterious Annotation of genetic variants using Neural Networks; dbSNP ID = SNP identifier; LOD = logarithm of the odds (for linkage); PolyPhen = polymorphism phenotyping, functional prediction of SNP impact on protein product; SNP = single nucleotide polymorphism.

  • * Pathogenicity prediction is presented for missense variants using PolyPhen, the CADD Phred scaled score and DANN scores. A CADD Phred scaled score (42) of 20 means that the variant is among the top 1% of deleterious variants in the human genome, and a score of 30 means that the variant is in the top 0.1%. For DANN, (43) a score of 0.96 identifies 92.1% of pathogenic variations from ClinVar (www.ncbi.nlm.nih.gov/clinvar) and 18.1% of false-positive benign variations; values greater than 0.98 predict protein-disrupting or -altering variants. Positive values for the per-family LOD score indicate a positive contribution to the linkage signal from each family carrying that variant.

  • Total number of alternative alleles observed across 117 sequenced individuals.

  • Genes not expressed in the brain (defined by reads per kilobase per million [RPKM] < 1 in developmental transcriptomics RNA sequencing data, representing 65% of mapped genes) are indicated.

  • § Variants present on the same haplotype in pedigree 18.

  • Variants present on the same haplotype in pedigree 138.